Literature DB >> 19837544

Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.

Jinglian Yan1, Guodong Tie, Brian Park, Yagai Yan, Philip T Nowicki, Louis M Messina.   

Abstract

OBJECTIVE: We sought to directly compare the effects of type 1 and type 2 diabetes on postischemic neovascularization and evaluate the mechanisms underlying differences between these groups. We tested the hypothesis that type 2 diabetic mice have a greater reduction in endothelial nitric oxide synthase (eNOS) expression, a greater increase in oxidative stress, and reduced arteriogenesis and angiogenesis, resulting in less complete blood flow recovery than type 1 diabetic mice after induction of hind limb ischemia.
METHODS: Hind limb ischemia was generated by femoral artery excision in streptozotocin-treated mice (model of type 1 diabetes), in Lepr(db/db) mice (model of type 2 diabetes), and in control (C57BL/6) mice. Dependent variables included eNOS expression and markers of arteriogenesis, angiogenesis, and oxidative stress.
RESULTS: Postischemia recovery of hind limb perfusion was significantly less in type 2 than in type 1 diabetic mice; however, neither group demonstrated a significant increase in collateral artery diameter or collateral artery angioscore in the ischemic hind limb. The capillary/myofiber ratio in the gastrocnemius muscle decreased in response to ischemia in control or type 1 diabetic mice but remained the same in type 2 diabetic mice. Gastrocnemius muscle eNOS expression was lower in type 1 and 2 diabetic mice than in control mice. This expression decreased after induction of ischemia in type 2 but not in type 1 diabetic mice. The percentage of endothelial progenitor cells (EPC) in the peripheral blood failed to increase in either diabetic group after induction of ischemia, whereas this variable significantly increased in the control group in response to ischemia. EPC eNOS expression decreased after induction of ischemia in type 1 but not in type 2 diabetic mice. EPC nitrotyrosine accumulation increased after induction of ischemia in type 2 but not in type 1 diabetic mice. EPC migration in response to vascular endothelial growth factor was reduced in type 1 and type 2 diabetic mice vs control mice. EPC incorporation into tubular structures was less effective in type 2 diabetic mice. Extensive fatty infiltration was present in ischemic muscle of type 2 but not in type 1 diabetic mice.
CONCLUSION: Type 2 diabetic mice displayed a significantly less effective response to hind limb ischemia than type 1 diabetic mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837544      PMCID: PMC2797079          DOI: 10.1016/j.jvs.2009.08.007

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  34 in total

1.  Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice.

Authors:  Vincent van Weel; Margreet de Vries; Peter J Voshol; Robert E Verloop; Paul H C Eilers; Victor W M van Hinsbergh; J Hajo van Bockel; Paul H A Quax
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-30       Impact factor: 8.311

2.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.

Authors:  G C Schatteman; H D Hanlon; C Jiao; S G Dodds; B A Christy
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy.

Authors:  Gian Paolo Fadini; Saverio Sartore; Mattia Albiero; Ilenia Baesso; Ellen Murphy; Mirko Menegolo; Franco Grego; Saula Vigili de Kreutzenberg; Antonio Tiengo; Carlo Agostini; Angelo Avogaro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-20       Impact factor: 8.311

4.  Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.

Authors:  Thomas Thum; Daniela Fraccarollo; Maximilian Schultheiss; Sabrina Froese; Paolo Galuppo; Julian D Widder; Dimitrios Tsikas; Georg Ertl; Johann Bauersachs
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

5.  Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia.

Authors:  Costanza Emanueli; Andrea Caporali; Nicolle Krankel; Brunella Cristofaro; Sophie Van Linthout; Paolo Madeddu
Journal:  Front Biosci       Date:  2007-01-01

6.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Authors:  Sajoscha A Sorrentino; Ferdinand H Bahlmann; Christian Besler; Maja Müller; Svenja Schulz; Nina Kirchhoff; Carola Doerries; Tibor Horváth; Anne Limbourg; Florian Limbourg; Danilo Fliser; Hermann Haller; Helmut Drexler; Ulf Landmesser
Journal:  Circulation       Date:  2007-06-25       Impact factor: 29.690

Review 8.  Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.

Authors:  Theodore Mazzone; Alan Chait; Jorge Plutzky
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

9.  Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.

Authors:  Po-Hsun Huang; Masataka Sata; Hiroaki Nishimatsu; Makoto Sumi; Yasunobu Hirata; Ryozo Nagai
Journal:  Biomed Pharmacother       Date:  2007-07-20       Impact factor: 6.529

10.  Human leptin enhances activation and proliferation of human circulating T lymphocytes.

Authors:  C Martín-Romero; J Santos-Alvarez; R Goberna; V Sánchez-Margalet
Journal:  Cell Immunol       Date:  2000-01-10       Impact factor: 4.868

View more
  55 in total

1.  Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.

Authors:  Christopher B Pattillo; Shyamal C Bir; Billy G Branch; Eric Greber; Xinggui Shen; Sibile Pardue; Rakesh P Patel; Christopher G Kevil
Journal:  Free Radic Biol Med       Date:  2010-11-09       Impact factor: 7.376

2.  A systematic approach to assess locoregional differences in angiogenesis.

Authors:  T Driesen; D Schuler; R Schmetter; C Heiss; M Kelm; J W Fischer; T Freudenberger
Journal:  Histochem Cell Biol       Date:  2015-11-02       Impact factor: 4.304

3.  Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.

Authors:  Sankarathi Balaiya; Maria B Grant; Joshua Priluck; Kakarla V Chalam
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

4.  Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Authors:  L Zazzeroni; G Lanzoni; G Pasquinelli; C Ricordi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2017-09-29

Review 5.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

6.  Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus.

Authors:  Chad L Carr; Yue Qi; Brian Davidson; Scott Chadderdon; Ananda R Jayaweera; J Todd Belcik; Cameron Benner; Aris Xie; Jonathan R Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

7.  Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes.

Authors:  Maulasri Bhatta; Jacey Hongjie Ma; Joshua J Wang; Jonna Sakowski; Sarah X Zhang
Journal:  Diabetologia       Date:  2015-06-11       Impact factor: 10.122

Review 8.  Endothelial Cell Redox Regulation of Ischemic Angiogenesis.

Authors:  Richard A Cohen; Colin E Murdoch; Yosuke Watanabe; Victoria M Bolotina; Alicia M Evangelista; Dagmar J Haeussler; Melissa D Smith; Yu Mei; XiaoYong Tong; Jingyan Han; Jessica B Behring; Markus M Bachschmid; Reiko Matsui
Journal:  J Cardiovasc Pharmacol       Date:  2016-06       Impact factor: 3.105

9.  Surface Tethering of Inflammation-Modulatory Nanostimulators to Stem Cells for Ischemic Muscle Repair.

Authors:  Jiayu Leong; Yu-Tong Hong; Yu-Fu Wu; Eunkyung Ko; Svyatoslav Dvoretskiy; Jye Yng Teo; Byoung Soo Kim; Kyeongsoo Kim; Hojeong Jeon; Marni Boppart; Yi Yan Yang; Hyunjoon Kong
Journal:  ACS Nano       Date:  2020-04-13       Impact factor: 15.881

10.  Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.

Authors:  Ashay D Bhatwadekar; E P Guerin; Yagna P R Jarajapu; Sergio Caballero; Carl Sheridan; David Kent; Laurence Kennedy; M Cecilia Lansang; Frank W Ruscetti; Carl J Pepine; Paul J Higgins; Stephen H Bartelmez; Maria B Grant
Journal:  Diabetes       Date:  2010-05-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.